Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial
Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial
复制标题
DOI:
10.1186/s12974-015-0425-2
复制
发表时间:
2015-11-06
影响因子:
9.3
通讯作者:
Ditor, David S.
中科院分区:
文献类型:
--
作者:
Allison, David J.;Ditor, David S.
Background: The purpose of the present study was to examine the efficacy of targeting inflammation as a means of improving mood following spinal cord injury (SCI) and explore the potential mechanisms of action.Methods: The study was a randomized, parallel-group, controlled, clinical trial (NCT02099890) whereby 20 participants with varying levels and severities of SCI were randomized (3:2) to either the treatment group, consisting of a 12-week anti-inflammatory diet, or control group. Outcome measures were assessed at baseline, 1 and 3 months, and consisted of CES-D scores of depression, markers of inflammation as assessed by various pro-and anti-inflammatory cytokines and several amino acids related to depression.Results: A significant group x time interaction was found for CES-D (Center for Epidemiologic studies Depression Scale) score (p = 0.01), the TRP/LNAA (tryptophan/large neutral amino acid) ratio (p = 0.04), the composite score of pro-inflammatory cytokines (p = 0.04), IL-1 beta (interleukin-1 beta) (p = 0.04), and IFN-gamma (interferon gamma) (p = 0.03). Pearson's r correlation showed significance between the Delta IL-1 beta and both the Delta CES-D score (r = 0.740, p < 0.01) and the Delta KYN/TRP (kynurenine/tryptophan) ratio (r = 0.536, p = 0.02). The Delta KYN/TRP ratio was also significantly correlated with the Delta CES-D score (r = 0.586, p = 0.01). Mediation analysis showed that the relationship between the Delta KYN/TRP ratio and the Delta CES-D score was mediated by the Delta IL-1 beta. Subgroup analysis showed that participants with high CES-D scores had significantly higher concentrations of IL-1 beta, and all correlations were maintained or strengthened within this subgroup.Conclusions: Overall, the results demonstrated the effectiveness of targeting inflammation as a means of improving mood in SCI, with potential mechanisms relating to the reduction in IL-1 beta and improvements in levels of neuroactive compounds related to the kynurenine pathway. Due to the limited sample size, results should be interpreted with caution; however, they are worthy of further examination due to the potential impact of inflammation on depression.